Researchers surveyed experts in fetal medicine and hematology to form a set of recommendations for managing HDFN.

Considerable variations have been observed in the postnatal management and outcomes of hemolytic disease of the fetus and newborn (HDFN) in centers across the globe, according to findings from an ...

Learn more about the potential benefits of delayed umbilical cord clamping, including increased blood flow and improved iron ...

A recent study showed limited data exist on the risks associated with anti-G during pregnancy, including the development of ...

A recent review showed that RhD-negative blood products carry the lowest risk for HDFN. Among women at risk for the development of hemolytic disease of the fetus and newborn (HDFN), Rhesus D ...

In pregnancies at risk of hemolytic disease of the fetus and newborn (HDFN), amniocentesis is used to identify the fetus’s ...

A case report described an infant with concurrent HDFN and SMA who was succesfully treated with an onasemnogene abeparvovec ...